Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eiko Lifesciences's yield on cost for the quarter that ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Eiko Lifesciences's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Eiko Lifesciences's highest Yield on Cost was 1.00. The lowest was 0.34. And the median was 0.51.
BOM:890189's 5-Year Yield-on-Cost % is not ranked *
in the Chemicals industry.
Industry Median: 1.76 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Eiko Lifesciences 5-Year Yield-on-Cost % Related Terms
BOM:890189 vs LIN, SHW, ECL: 5-Year Yield-on-Cost % Comparison
For the Specialty Chemicals subindustry, Eiko Lifesciences's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiko Lifesciences 5-Year Yield-on-Cost % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Eiko Lifesciences's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Eiko Lifesciences's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Eiko Lifesciences (BOM:890189) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Eiko Lifesciences and its competitors. Over the past decade, Eiko Lifesciences' 5-Year Yield-on-Cost % has ranged from 0.34 to 1.00. According to the industry distribution chart, Eiko Lifesciences ranks #999999 out of 1035 companies in the Chemicals industry.
Is Eiko Lifesciences' 5-Year Yield-on-Cost % too high?
Eiko Lifesciences' current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 1.00. Based on the distribution chart, Eiko Lifesciences ranks #999999 out of 1035 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Eiko Lifesciences has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Eiko Lifesciences' 5-Year Yield-on-Cost % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Eiko Lifesciences ranks #999999 out of 1035 companies for 5-Year Yield-on-Cost %. This places Eiko Lifesciences in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.76. Historically, Eiko Lifesciences' own 5-Year Yield-on-Cost % has ranged from 0.34 to 1.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Chemicals company?
The median 5-Year Yield-on-Cost % among Chemicals companies is 1.76, based on 1,035 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Eiko Lifesciences and its competitors. For the Chemicals industry, the median 5-Year Yield-on-Cost % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiko Lifesciences's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiko Lifesciences stock overvalued right now?
Eiko Lifesciences (BOM:890189) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is ₹36.87, compared to a current price of ₹22.90 — trading 37.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Eiko Lifesciences' overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Eiko Lifesciences (BOM:890189), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiko Lifesciences (BOM:890189) Overvalued in 2026?
Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued.
The current stock price of ₹22.90 is trading 37.9% below its estimated GF Value™ of ₹36.87.
Key valuation signals for BOM:890189:
5-Year Yield-on-Cost %: 0.00
GF Value™: ₹36.87 vs. price of ₹22.90 (37.9% below fair value)
No single metric tells the full story. See the BOM:890189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
70GF Score
Get the complete analysis for BOM:890189
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:890189 has been successfully added to your 
